{
    "nctId": "NCT02681640",
    "briefTitle": "uPAR PET/CT for Preoperative Staging of Breast Cancer Patients",
    "officialTitle": "Phase II Trial: uPAR PET/CT for Preoperative Staging of Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Sensitivity and specificity of uPAR PET/CT in identifying axillary lymph node metastases from breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Biopsy-verified breast cancer\n* Primary tumor more than 2 cm (ultrasound or clinically)\n* The participants must be capable of understanding and giving full informed written consent\n\nExclusion Criteria:\n\n* Pregnancy\n* Lactation/breast feeding\n* Weight above 140 kg\n* Treatment with neoadjuvant chemotherapy\n* Known allergy towards the IMP",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}